AU9298098A - Amino-substituted compounds, methods, and compositions for inhibiting parp activity - Google Patents
Amino-substituted compounds, methods, and compositions for inhibiting parp activityInfo
- Publication number
- AU9298098A AU9298098A AU92980/98A AU9298098A AU9298098A AU 9298098 A AU9298098 A AU 9298098A AU 92980/98 A AU92980/98 A AU 92980/98A AU 9298098 A AU9298098 A AU 9298098A AU 9298098 A AU9298098 A AU 9298098A
- Authority
- AU
- Australia
- Prior art keywords
- amino
- compositions
- methods
- substituted compounds
- parp activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/10—Aza-phenanthrenes
- C07D221/12—Phenanthridines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/34—Phthalazines with nitrogen atoms directly attached to carbon atoms of the nitrogen-containing ring, e.g. hydrazine radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/93—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92252097A | 1997-09-03 | 1997-09-03 | |
| US08922520 | 1997-09-03 | ||
| US7950798A | 1998-05-15 | 1998-05-15 | |
| US09079507 | 1998-05-15 | ||
| US14517798A | 1998-09-01 | 1998-09-01 | |
| US09145177 | 1998-09-01 | ||
| PCT/US1998/018187 WO1999011622A1 (en) | 1997-09-03 | 1998-09-02 | Amino-substituted compounds, methods, and compositions for inhibiting parp activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU9298098A true AU9298098A (en) | 1999-03-22 |
Family
ID=27373491
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU92980/98A Abandoned AU9298098A (en) | 1997-09-03 | 1998-09-02 | Amino-substituted compounds, methods, and compositions for inhibiting parp activity |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU9298098A (en) |
| WO (1) | WO1999011622A1 (en) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6235748B1 (en) | 1997-09-03 | 2001-05-22 | Guilford Pharmaceuticals Inc. | Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
| SK287338B6 (en) | 1999-01-11 | 2010-07-07 | Agouron Pharmaceuticals, Inc. | Tricyclic compound, its thereof and pharmaceutical composition containing thereof |
| ECSP003637A (en) | 1999-08-31 | 2002-03-25 | Agouron Pharma | TRICYCLE POLY INHIBITORS (ADP-RIBOSA) POLYMERASES |
| US6531464B1 (en) | 1999-12-07 | 2003-03-11 | Inotek Pharmaceutical Corporation | Methods for the treatment of neurodegenerative disorders using substituted phenanthridinone derivatives |
| US6476048B1 (en) | 1999-12-07 | 2002-11-05 | Inotek Pharamaceuticals Corporation | Substituted phenanthridinones and methods of use thereof |
| US6534651B2 (en) | 2000-04-06 | 2003-03-18 | Inotek Pharmaceuticals Corp. | 7-Substituted isoindolinone inhibitors of inflammation and reperfusion injury and methods of use thereof |
| US7122679B2 (en) | 2000-05-09 | 2006-10-17 | Cephalon, Inc. | Multicyclic compounds and the use thereof |
| WO2003015785A1 (en) | 2001-08-15 | 2003-02-27 | Icos Corporation | 2h-phthalazin-1-ones and methods for use thereof |
| MX2007008771A (en) | 2005-01-19 | 2007-09-11 | Mgi Gp Inc | Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting parp. |
| EP1896032B1 (en) | 2005-06-14 | 2012-10-31 | Merck Sharp & Dohme Corp. | The preparation and use of compounds as protease inhibitors |
| US9150628B2 (en) | 2005-11-14 | 2015-10-06 | Centre National De La Recherche Scientifique (Cnrs) | PARP inhibitors |
| AR059898A1 (en) | 2006-03-15 | 2008-05-07 | Janssen Pharmaceutica Nv | DERIVATIVES OF 3-CIANO-PIRIDONA 1,4-DISUSTITUTED AND ITS USE AS ALLOSTERIC MODULATORS OF MGLUR2 RECEIVERS |
| TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| NZ584145A (en) | 2007-09-14 | 2012-03-30 | Ortho Mcneil Janssen Pharm | 1',3'-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h, 1'h-[1,4'] bipyridinyl-2'-ones |
| DK2209375T3 (en) | 2007-10-03 | 2014-10-06 | Eisai Inc | PARP-INHIBITOR RELATIONS, PREPARATIONS AND PROCEDURES FOR USE THEREOF |
| JP5547194B2 (en) | 2008-09-02 | 2014-07-09 | ジャンセン ファーマシューティカルズ， インコーポレイテッド． | 3-Azabicyclo [3.1.0] hexyl derivatives as modulators of metabotropic glutamate receptors |
| ES2401691T3 (en) | 2008-11-28 | 2013-04-23 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | Indole and benzoxacin derivatives as modulators of metabotropic glutamate receptors |
| CN102439008B (en) | 2009-05-12 | 2015-04-29 | 杨森制药有限公司 | 1,2,3-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| NZ596053A (en) | 2009-05-12 | 2013-05-31 | Janssen Pharmaceuticals Inc | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| WO2012062750A1 (en) | 2010-11-08 | 2012-05-18 | Janssen Pharmaceuticals, Inc. | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
| CN103261195B (en) | 2010-11-08 | 2015-09-02 | 杨森制药公司 | The purposes of 1,2,4-triazolo [4,3-a] pyridine derivate and the positive allosteric modulators as MGLUR2 acceptor thereof |
| CA2815002C (en) | 2010-11-08 | 2019-10-22 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| JP5699223B2 (en) | 2010-12-02 | 2015-04-08 | シャンハイ デュァ ノボ ファルマテック カンパニー リミテッド | Heterocyclic derivatives, their synthesis and medical applications |
| ES2773272T3 (en) * | 2012-08-08 | 2020-07-10 | Merck Patent Gmbh | Derivatives of (aza-) isoquinolinone |
| AU2014248568B2 (en) * | 2013-03-12 | 2017-07-13 | Curegenix, Inc. | Compounds for treatment of cancer |
| CN105120867A (en) | 2013-03-14 | 2015-12-02 | 广州源生医药科技有限公司 | Compounds for treatment of fibrosis diseases |
| JO3368B1 (en) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | 6,7-DIHYDROPYRAZOLO[1,5-a]PYRAZIN-4(5H)-ONE COMPOUNDS AND THEIR USE AS NEGATIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
| JO3367B1 (en) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | 1,2,4-TRIAZOLO[4,3-a]PYRIDINE COMPOUNDS AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS |
| KR20220049612A (en) | 2014-01-21 | 2022-04-21 | 얀센 파마슈티카 엔.브이. | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
| ES2748633T3 (en) | 2014-01-21 | 2020-03-17 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators of the subtype 2 metabotropic glutamatergic receptor and their use |
| TW201702218A (en) | 2014-12-12 | 2017-01-16 | 美國杰克森實驗室 | Compositions and methods relating to the treatment of cancer, autoimmune disease, and neurodegenerative disease |
| US11261466B2 (en) | 2015-03-02 | 2022-03-01 | Sinai Health System | Homologous recombination factors |
| CN110698411B (en) * | 2018-07-09 | 2023-05-09 | 四川大学 | 4- (aminoalkyl) phthalazine-1-ketone compound, preparation method and application thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2593798A (en) * | 1947-05-22 | 1952-04-22 | Searle & Co | Aminoalkylamino isoquinoline compounds |
| US2638472A (en) * | 1949-08-26 | 1953-05-12 | Hoffmann La Roche | 1-benzyl-5, 6, 7, 8-tetrahydroisoquinoline and derivatives thereof |
| US2666059A (en) * | 1950-08-11 | 1954-01-12 | American Cyanamid Co | Anilinoisoquinolines and processes of preparing the same |
| US2700040A (en) * | 1951-05-21 | 1955-01-18 | Smith Kline French Lab | Aminoalkylaminoisoquinolines |
| US2892841A (en) * | 1956-04-02 | 1959-06-30 | Grace W R & Co | Process for aminating nitrogen-containing heterocyclic compounds |
| GB1173227A (en) * | 1967-06-22 | 1969-12-03 | Koninklijke Pharma Fab Nv | Amino-Isoquinolines |
| FR2081572B1 (en) * | 1970-03-12 | 1973-04-06 | Rhone Poulenc Sa | |
| GB1545767A (en) * | 1976-06-30 | 1979-05-16 | Aspro Nicholas Ltd | Isoquinoline derivatives |
| DE2650226A1 (en) * | 1976-11-02 | 1978-05-11 | Henkel Kgaa | 1,3,4-Tri:amino-isoquinoline hair dye coupler and developer - prepd. by hydrogenating 1,3-di:amino-4-nitroso-isoquinoline using a palladium catalyst |
| DE2818403A1 (en) * | 1978-04-27 | 1979-11-08 | Hoechst Ag | NEW ISOCHINOL DERIVATIVES AND METHOD FOR THEIR PRODUCTION |
| GB8908229D0 (en) * | 1989-04-12 | 1989-05-24 | Smithkline Beckman Intercredit | Compounds |
| GB9404485D0 (en) * | 1994-03-09 | 1994-04-20 | Cancer Res Campaign Tech | Benzamide analogues |
| US5589483A (en) * | 1994-12-21 | 1996-12-31 | Geron Corporation | Isoquinoline poly (ADP-ribose) polymerase inhibitors to treat skin diseases associated with cellular senescence |
| HUP9901739A3 (en) * | 1996-04-13 | 2000-06-28 | Astrazeneca Ab | Aminoisoquinolines and aminothienopyridine derivatives, process for producing thereof and pharmaceutical compositions containing them |
-
1998
- 1998-09-02 AU AU92980/98A patent/AU9298098A/en not_active Abandoned
- 1998-09-02 WO PCT/US1998/018187 patent/WO1999011622A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999011622A1 (en) | 1999-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU9298098A (en) | Amino-substituted compounds, methods, and compositions for inhibiting parp activity | |
| AU9297898A (en) | Thioalkyl compounds, methods, and compositions for inhibiting parp activity | |
| ZA988012B (en) | Amino-substituted compounds methods and compositions for inhibiting parp activity | |
| AU9298198A (en) | Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity | |
| AU2217400A (en) | Phenazine compounds, methods and pharmaceutical compositions for inhibiting parp | |
| HUP0004693A3 (en) | Oxo-substituted compounds inhibiting parp activity, pharmaceutical compositions containing them and process for preparation the compounds | |
| AU1433299A (en) | Disinfecting agent | |
| AU2595697A (en) | Compounds and compositions for delivering active agents | |
| AU9790198A (en) | Compounds and methods | |
| AU1940701A (en) | Methods and systems for market clearance | |
| AU4073997A (en) | 1,4-heterocyclic metallprotease inhibitors | |
| AU4723296A (en) | Compositions having depigmenting activity, and uses thereof | |
| AU6318196A (en) | Novel benzimidazole derivatives having cgmp-phosphodisterase inhibiting activity | |
| ZA988018B (en) | Carboxamide compounds, methods, and compositions for inhibiting parp activity. | |
| AU3701397A (en) | Anti-herpesviral agent | |
| AU1390199A (en) | Compositions and methods for inhibiting the activity of certain genes | |
| AU3123697A (en) | Angiostatic compounds | |
| AU4806497A (en) | Glyoxylic compound comprising one or more active ingredient | |
| AU4415797A (en) | New pde iv inhibitors: "bis-compounds" | |
| ZA989521B (en) | Methods and compositions for enhancing herbicidal activity. | |
| EP1646395B8 (en) | Methods and compositions for regulating lymphocyte activity | |
| AUPO982097A0 (en) | Methods and compositions for use therein | |
| AU1046799A (en) | Compound, composition and use | |
| AU8492598A (en) | Methods and compositions for tumor reduction | |
| AU3852997A (en) | Phenoxypropanolamines having beta3-adrenergic antagonist activity |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |